🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to assess the effectiveness of zanzali...
Status
Recruiting
Location
The University of Alabama at Birmingham
Start Date
2025-07-21
Trial ID
NCT06943755
Treatments Being Tested
Tuberous Sclerosis Complex (TSC) is a multi-system disease, usually present...
Status
Completed
Location
Boston Children's Hospital
Start Date
2011-01
Trial ID
NCT01289912
This record combines the results of CRAD001K24133 and CRAD001K24133E1. The ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-27
Trial ID
NCT01595009
Treatments Being Tested
The primary objective of the study is to evaluate the safety of idelalisib ...
Status
Completed
Location
Clearview Cancer Institute
Start Date
2010-03-25
Trial ID
NCT01088048
The purpose of this study is to determine whether exemestane plus everolimu...
Status
Unknown
Location
Unimed Medical Institute
Start Date
TBD
Trial ID
NCT02025712
Treatments Being Tested
The study is designed as an open-label, prospective, single arm, multicente...
Status
Completed
Location
Charité-Universitätsmedizin, Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Campus Virchow-Klinikum
Start Date
2015-08
Trial ID
NCT02113800
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Status
Completed
Location
University of California Davis Cancer Center
Start Date
2008-12
Trial ID
NCT00814788
Treatments Being Tested
CTCL is a rare form of lymphoma of the skin. While early stages are usually...
Status
Terminated
Location
Boston Medical Center
Start Date
2012-06
Trial ID
NCT01637090
Treatments Being Tested
This study will evaluate the safety and efficacy of RAD001 in treating pati...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2009-04
Trial ID
NCT00790400
Treatments Being Tested
The goal of this clinical research study is to learn if exemestane and ever...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2012-09
Trial ID
NCT01627067
Treatments Being Tested